TGF drives immune evasion in genetically reconstituted colon cancer metastasis

A two-minute animation that explains the discovery published in Nature magazine (14/02/2018). A team headed by ICREA researcher Eduard Batlle at IRB Barcelona discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer. The results pave the way to the use of immunotherapy to treat aggressive colon tumours and their metastasis.